Medialis assessed the data and selected a systematic review and network meta analysis (mixed treatment meta analysis) to model expected performance of the client’s product against its competitors.
Medialis completed the study and published it in a high impact factor pain journal.
Jandhyala R, Fullarton JR, Bennett MI.
J Pain Symptom Manage. 2013 Feb 1. doi:pii: S0885-3924(12)00815-9. 10.1016/j.jpainsymman.2012.09.009. [Epub ahead of print]
Medialis were able to carry out full salesforce training, and generate promotional slide deck and leave pieces.
Formal 1:1 online key opinion leader briefing was carried, as well as an advisory board on initial completion of the project to obtain feedback.
The following claims were generated:
This mixed-treatment analysis suggests that FBT, ODT, and OTFC might provide more efficacious treatment options than oral morphine for BTcP.